Replay available

IRLAB Therapeutics (Stockholm:IRLAB A) Q2 2026 Earnings Call

IRLAB Therapeutics (Stockholm:IRLAB A) Q2 2026 earnings call, held 2026-08-26. Watch the replay and read the transcript on 6ix.

Wed, August 26, 2026 at 4:00 AMendedReplay
IRLAB Therapeutics (Stockholm:IRLAB A) Q2 2026 Earnings Call
Company
Irlab Therapeutics AB (OMXSTO:IRLAB_A)
Period
Q2 2026 earnings call
Date
Wed, Aug 26, 2026, 4:00 AM ET
Replay
Watch the replay on this page · 34 min

On 6ix: 6ix.com/event/irlab-therapeutics-ab-publ-irlaba-q2-2026-earnings-call

Replay

Transcript

Automated transcript · Written by software from the replay's audio. It can mishear names and figures; the replay is the record.

0:00 Welcome to Tilden Harre Live. Here presentation. I'm for I'm Kristina Thorfgaard Senior Vice President, R and D, Nicolas Waters OG CFO, Gustav Alberg. From

4:34 our cash flow. Operating profit, So now we're actually looking

11:49 at hearing about our maintenance analyst for a drug for a RUPA under warrant. We will then for a portion, debit data report, mainly a market access aspect and also please reward and Tom Europe. Some the commercial hard premium pricing, what saw or the commercial market.

12:55 Unveiled it good argument, so we can have a partner in this group. Nesta Buildpak. The Horox inlet, that's our partner here and the Kansk Group, the store of ex Regulator from FTR, for at Maesla Flam and Next slide, please.

14:27 Clinic. We are also set that external laboratory, for

32:59 example technology access Okay. I don't

Follow Irlab Therapeutics AB into a list and get an email when it puts out news.

Latest news releases

Companies on this call

Speakers

Kristina Torfgård

CEO

Gustav Albert

CFO

Nikolas Waters

Senior Vice President R&D

More from Irlab Therapeutics AB